Epstein–Barr virus (EBV) is arguably one of the most successful pathogens of humans,
persistently infecting over ninety percent of the world's population. Despite this high …

ABSTRACT The Epstein-Barr virus (EBV) is a gamma-herpes virus which establishes latent,
lifelong infection in more than 95% of the human adult population. Despite its growth …

Publisher Summary This chapter focuses on both on the effects of Epstein–Barr virus (EBV)
on human B cells and on the immune response to viral infection. The chapter also presents …

Epstein-Barr virus (EBV) is a member of the human herpesvirus family and, like many other
herpesviruses, maintains a lifelong latent association with B lymphocytes and a permissive …

The human γ-herpesvirus, Epstein-Barr virus (EBV), has growth-transforming potential in
vivo and in vitro. Despite this, most healthy carriers remain free of EBV-associated …

Epstein-Barr virus (EBV) is usually acquired silently early in life and carried thereafter as an
asymptomatic infection of the B lymphoid system. However, many circumstances disturb the …

Epstein-Barr virus (EBV) is a ubiquitous human herpesvirus that persistently infects 85% of
the adult population worldwide. In this report, we examine the proliferative response and …

EBV is a gammaherpesvirus that can establish both nonproductive (latent) and productive
(lytic) infections within the cells of its host. Although T cell responses to EBV latent proteins …

Epstein-Barr virus (EBV) is an oncogenic human herpesvirus that persistently infects
approximately 90% of the world's population. Such a remarkably sustained of viral infectivity …

Publisher Summary Epstein–Barr Virus (EBV) is a unique viral pathogen for man and its
target for infection is the immune system itself. Not only are B lymphocytes infected by the …